This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Community Health Systems Stock Falls 7% Amid Debt & Other Pressures
by Zacks Equity Research
Shares of CYH decline 7%. Heavy debt, soft patient volumes and ongoing investor concerns keep pressure on the hospital operator.
LHNegative Net Change UHSNegative Net Change CYHPositive Net Change
medical
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS expands into Canada and Europe while facing regulatory hurdles and execution risks in weight-loss care.
TDOCPositive Net Change GDRXNegative Net Change HIMSPositive Net Change
medical medical-devices
Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?
by Urmimala Biswas
Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.
IQVNegative Net Change GHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-report healthcare medical medical-devices valuation
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
by Zacks Equity Research
Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.
NVONegative Net Change LLYNegative Net Change VKTXNegative Net Change GPCRNegative Net Change
biotechnology biotechs medical pharmaceuticals
Is the Options Market Predicting a Spike in Avantor Stock?
by Zacks Equity Research
Investors need to pay close attention to AVTR stock based on the movements in the options market lately.
AVTRPositive Net Change
medical
Is the Options Market Predicting a Spike in Aveanna Healthcare Stock?
by Zacks Equity Research
Investors need to pay close attention to AVAH stock based on the movements in the options market lately.
AVAHNegative Net Change
medical
Can Flex's Cash Flow & Market Strength Offset Ongoing Macro Pressures?
by Shreya Majumder
Flex enters the second half of fiscal 2026 with rising AI demand, strong cash flow and expanding data center momentum despite competitive and macro pressures.
JBLPositive Net Change FLEXPositive Net Change SANMPositive Net Change
artificial-intelligence automation autonomous-vehicles business-services cloud-computing medical tech-stocks
ALGN Stock Rises on Thailand Launch of Invisalign With MAOB
by Zacks Equity Research
Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.
ALGNPositive Net Change OMCLPositive Net Change ILMNPositive Net Change BTSGPositive Net Change
medical
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
by Zacks Equity Research
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
ISRGNegative Net Change MEDPNegative Net Change CARLPositive Net Change
medical medical-devices
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
by Zacks Equity Research
OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.
BSXNegative Net Change ISRGNegative Net Change OPKPositive Net Change MEDPNegative Net Change
medical medical-devices
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
by Zacks Equity Research
TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance.
OMCLPositive Net Change ILMNPositive Net Change TNDMPositive Net Change BTSGPositive Net Change
medical
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
by Zacks Equity Research
Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
OMCLPositive Net Change ILMNPositive Net Change RMDNegative Net Change BTSGPositive Net Change
medical medical-devices
Best Growth Stocks to Buy for December 9th
by Zacks Equity Research
SANM, ALL and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 9, 2025
ALLPositive Net Change SANMPositive Net Change PAHCNegative Net Change
construction finance medical
New Strong Sell Stocks for December 9th
by Zacks Equity Research
BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.
BRDCYPositive Net Change BRBRPositive Net Change AZTAPositive Net Change
auto-tires-trucks consumer-staples medical
Will Cobenfy Become a Growth Driver for BMY's Neuroscience Business?
by Ekta Bagri
Bristol Myers Squibb moves forward with its ADEPT-2 study on Cobenfy, delaying data to next year but boosting investor sentiment.
BIIBNegative Net Change BMYNegative Net Change LLYNegative Net Change
biotechnology biotechs medical pharmaceuticals
Can UNH's AI-Powered Virtual Assistance Enhance Member Experience?
by Zacks Equity Research
UnitedHealth's AI-powered virtual assistants aim to simplify claims, boost engagement and deliver faster, more intuitive healthcare support.
UNHNegative Net Change HUMNegative Net Change ELVNegative Net Change
artificial-intelligence insurance medical
PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know
by Zacks Equity Research
Praxis stock soars after late-stage data show strong efficacy for ulixacaltamide therapy in essential tremor and momentum builds toward an early-2026 regulatory filing.
ANIPPositive Net Change CRMDPositive Net Change ARQTNegative Net Change PRAXNegative Net Change
biotechnology biotechs medical pharmaceuticals
Incyte's Rare Blood Cancer Therapy Gets FDA's Breakthrough Status
by Zacks Equity Research
INCY secures FDA Breakthrough Therapy status for INCA033989 after early data show rapid and sustained platelet normalization in essential thrombocythemia patients.
INCYNegative Net Change ANIPPositive Net Change CRMDPositive Net Change ARQTNegative Net Change
biotechnology biotechs medical pharmaceuticals
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio
by Zacks Equity Research
CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.
BSXNegative Net Change CNMDNegative Net Change ISRGNegative Net Change MEDPNegative Net Change
medical medical-devices
Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook
by Urmimala Biswas
Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.
ILMNPositive Net Change GHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-report healthcare medical medical-devices
Bet on These 3 Stocks With Upgraded Broker Ratings Amid Uncertainties
by Swayta Shah
Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.
ILMNPositive Net Change NEMPositive Net Change CMCNegative Net Change
basic-materials medical
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
by Moumi Mondal
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
ABTNegative Net Change HOLXPositive Net Change QGENNegative Net Change
medical medical-devices
3 Generic Drug Stocks to Watch Amid Changing U.S. Landscape
by Sundeep Ganoria
Generic drugmakers face U.S. pricing pressure, but TEVA, SDZNY and RDY gain momentum through complex generics and biosimilars.
RDYNegative Net Change TEVAPositive Net Change SDZNYNegative Net Change
medical
Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus
by Abhinab Dasgupta
Veracyte, Las Vegas Sands and 3M shine as Zacks spotlights standout stock gains and portfolio wins amid shifting market sentiment.
KONegative Net Change AMGNNegative Net Change MMMPositive Net Change MUPositive Net Change TMONegative Net Change LRCXPositive Net Change LVSNegative Net Change AUPositive Net Change FOLDPositive Net Change MTZPositive Net Change VCYTNegative Net Change
consumer-discretionary medical precious-metals
ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
by Indrajit Bandyopadhyay
Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.
MDTNegative Net Change SYKNegative Net Change ISRGNegative Net Change
medical medical-devices